Real-World Effectiveness of Omalizumab Treatment in Adult Asthma Patients
Omalizumab treatment effectively reduces SAE and improves lung function and asthma control. Blood neutrophil counts and serum total IgE may be potential biomarkers for predicting favorable responses to omalizumab treatment.
Authors
- Chungsoo Kim (ORCID: https://orcid.org/0000-0003-1802-1777)
- Rae Woong Park (ORCID: https://orcid.org/0000-0003-4989-3287)
- Jae-Hyuk Jang (ORCID: https://orcid.org/0000-0002-4225-7117)
- ChulHyoung Park
- Eunyoung Lee (ORCID: https://orcid.org/0000-0002-9440-9119)
- Hae‐Sim Park (ORCID: https://orcid.org/0000-0003-2614-0303)
- Youngsoo Lee (ORCID: https://orcid.org/0000-0001-8918-9353)
Institutions
- Yale New Haven Hospital (US)
- Yale University (US)
- Ajou University (KR)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Yonsei Medical Journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.3349/ymj.2024.0320
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Health and Welfare
- Korea Health Industry Development Institute